Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor learning induces myelin-related white matter changes revealed by MRI-based in vivo histology.

Communications biology·2026
Same author

Fine-tuning the yeast GAL10 promoter and growth conditions for efficient recombinant membrane protein production and purification.

Protein science : a publication of the Protein Society·2025
Same author

Longitudinal Changes of Quantitative Brain Tissue Properties Induced by Balance Training.

Human brain mapping·2025
Same author

Prior knowledge changes initial sensory processing in the human spinal cord.

Science advances·2025
Same author

Hebbian plasticity induced by temporally coincident BCI enhances post-stroke motor recovery.

Scientific reports·2024
Same author

Changes in Cortical Microstructure of the Human Brain Resulting from Long-Term Motor Learning.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2023

Related Experiment Video

Updated: May 22, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis.

Katja Scheffler1, Markus Krohn, Tina Dunkelmann

  • 1Department of Neurology, Neurodegeneration Research Laboratory (NRL), Universities of Rostock, Rostock, Germany.

Acta Neuropathologica
|April 25, 2012
PubMed
Summary

Mitochondrial DNA (mtDNA) variations impact brain energy metabolism and microglial function, influencing Alzheimer's disease (AD) pathology. Enhanced mitochondrial function in microglia reduces amyloid-beta accumulation, suggesting a key role for mitochondrial health in neuroprotection.

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 22, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

Area of Science:

  • Neuroscience
  • Genetics
  • Mitochondrial Biology

Background:

  • Mitochondrial DNA (mtDNA) mutations and inheritance are linked to age-related neurodegenerative diseases.
  • mtDNA alterations affect cellular energy metabolism, oxidative stress, and proteostasis.
  • Alzheimer's disease (AD) involves cerebral beta-amyloid (Aβ) accumulation and neurodegeneration.

Purpose of the Study:

  • To investigate the role of specific mtDNA polymorphisms in brain proteostasis regulation.
  • To establish novel mitochondrial congenic mouse models for Alzheimer's disease research.
  • To determine how mtDNA variations influence microglial activity and Aβ deposition.

Main Methods:

  • Creation of mitochondrial conplastic mouse lines with pure C57BL/6 nuclear backgrounds.
  • Crossing females from FVB/N, AKR/J, and NOD/LtJ strains with C57BL/6 males for over ten generations.
  • Analysis of mtDNA polymorphism effects on mitochondrial energy metabolism, ATP production, and microglial activity.

Main Results:

  • Specific mtDNA polymorphisms differentially affected mitochondrial energy metabolism and ATP production.
  • mtDNA variations influenced ATP-driven microglial activity.
  • Increased ATP levels and microglial activity correlated with decreased cerebral Aβ accumulation.

Conclusions:

  • mtDNA polymorphisms play a significant role in regulating brain proteostasis and AD pathogenesis.
  • Enhanced mitochondrial function in microglia, indicated by increased ATP levels, is associated with reduced Aβ burden.
  • Reduced mitochondrial function in microglia may be a causative factor in age-related cerebral proteopathies like AD.